Finafloxacin
Back to searchMolecule Structure
Scientific Name
Finafloxacin
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09047
http://www.drugbank.ca/drugs/DB09047
Brand Name(s)
Xtoro
Company Owner(s)
Merlion Pharmaceuticals Gmbh
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL3390827 |
Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL3038508 |
DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL3390828 |
DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL3038482 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1002869 |
DrugBank | DB09047 |
PubChem: Thomson Pharma | 16669755 |
PubChem | 11567473 |
Nikkaji | J2.714.451I |
EPA CompTox Dashboard | DTXSID10175096 |
DrugCentral | 4920 |
ChemicalBook | CB42605885 |
Guide to Pharmacology | 10809 |
rxnorm | FINAFLOXACIN |
ChEBI | 85176 |
ZINC | ZINC000003985346 |